Oppenheimer & Co’s Enlivex Ltd ENLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-22
Closed -$8K 1318
2017
Q2
$8K Sell
22
-2
-8% -$607 ﹤0.01% 1294
2017
Q1
$11K Sell
24
-17
-41% -$11.2K ﹤0.01% 1283
2016
Q4
$26K Sell
41
-30
-42% -$25.4K ﹤0.01% 1260
2016
Q3
$73K Sell
71
-15
-17% -$15.2K ﹤0.01% 1229
2016
Q2
$82K Sell
86
-18
-17% -$22.3K ﹤0.01% 1174
2016
Q1
$155K Sell
104
-27
-21% -$48.1K ﹤0.01% 1145
2015
Q4
$305K Buy
131
+5
+4% +$14.1K 0.01% 951
2015
Q3
$384K Buy
126
+7
+6% +$25.5K 0.01% 905
2015
Q2
$490K Buy
119
+35
+42% +$130K 0.01% 885
2015
Q1
$301K Buy
84
+57
+211% +$244K 0.01% 1106
2014
Q4
$104K Buy
+27
New +$98.7K ﹤0.01% 1323

Other funds holding ENLV

Oppenheimer & Co's ENLV Position: Q3 2017 in Review

Oppenheimer & Co sold out of Enlivex Ltd (ENLV) in Q3 2017, closing a stake of 22 shares — an estimated $8K sold.

Oppenheimer & Co first reported a position in ENLV in Q4 2014 and held it in 11 quarters. The position peaked at $490K in Q2 2015. 2 funds tracked by Wall St. Rank hold ENLV as of Q3 2017.

  • Oppenheimer & Co reported no remaining Enlivex Ltd position as of Q3 2017 after selling out during the quarter.
  • Oppenheimer & Co sold 22 Enlivex Ltd shares in Q3 2017, an estimated $8K.
  • Oppenheimer & Co first reported a position in Enlivex Ltd in Q4 2014 and held it in 11 quarters.
  • Oppenheimer & Co's Enlivex Ltd position peaked at $490K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held Enlivex Ltd as of Q3 2017.

Based on Oppenheimer & Co's 13F filing for Q3 2017, filed 9 Nov 2017.